Non-cirrhotic, Chronic Hepatitis B
1 clinical trials · Condition
◉ Watch Non-cirrhotic, Chronic Hepatitis B
| Record | Firm | Date |
|---|---|---|
| TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load. (NCT05195450) | Institute of Liver and Biliary Sciences, India | 2022-02-23 |
Track Non-cirrhotic, Chronic Hepatitis B automatically
Every clearance here is in the API, with alerts when new ones post.